The estimated Net Worth of Devashish Ohri is at least $9.73 Million dollars as of 27 May 2021. Mr. Ohri owns over 100,000 units of Avantor stock worth over $6,434,046 and over the last 5 years he sold AVTR stock worth over $0. In addition, he makes $3,292,320 as Executive Vice President - AMEA at Avantor.
Sign up
Mr. Ohri AVTR stock SEC Form 4 insiders trading
Devashish has made over 11 trades of the Avantor stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 100,000 units of AVTR stock worth $2,321,000 on 27 May 2021.
The largest trade he's ever made was exercising 103,440 units of Avantor stock on 5 October 2020 worth over $165,504. On average, Devashish trades about 35,086 units every 29 days since 2020. As of 27 May 2021 he still owns at least 239,095 units of Avantor stock.
You can see the complete history of Mr. Ohri stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Devashish Ohri biography
Devashish Ohri is Executive Vice President, AMEA region of the company. Devashish Ohri is our Executive Vice President, AMEA, a position he has held since 2014. Prior to joining us, Mr. Ohri acted as Managing Director, South Asia for Life Technologies, a biotechnological company, from 2010 to 2014.
What is the salary of Devashish Ohri?
As the Executive Vice President - AMEA of Avantor, the total compensation of Devashish Ohri at Avantor is $3,292,320. There are 4 executives at Avantor getting paid more, with Michael Stubblefield having the highest compensation of $16,995,300.
How old is Devashish Ohri?
Devashish Ohri is 53, he's been the Executive Vice President - AMEA of Avantor since 2014. There are 15 older and 12 younger executives at Avantor. The oldest executive at Avantor Inc. is Rajiv Gupta, 74, who is the Chairman of the Board.
What's Devashish Ohri's mailing address?
Devashish's mailing address filed with the SEC is RADNOR CORPORATE CENTER, BUILDING ONE,, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA, 19087.
Insiders trading at Avantor
Over the last 5 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri und Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.
What does Avantor do?
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com
What does Avantor's logo look like?
Complete history of Mr. Ohri stock trades at Avantor
Avantor executives and stock owners
Avantor executives and other stock owners filed with the SEC include:
-
Michael Stubblefield,
President, Chief Executive Officer, Director -
Thomas Szlosek,
Chief Financial Officer, Executive Vice President -
Michael Stubblefield,
Pres, CEO & Director -
Gerard Brophy,
Executive Vice President - Biopharma Production -
Devashish Ohri,
Executive Vice President - AMEA -
Frederic Vanderhaegen,
Executive Vice President - Americas and Europe -
Thomas A. Szlosek,
Exec. VP & CFO -
Frederic Vanderhaegen,
Exec. VP of Americas & Europe -
Dr. Gerald Brophy Ph.D.,
Exec. VP of Biopharma Production -
Michael Wondrasch,
Exec. VP & Chief Information Officer -
Rajiv Gupta,
Chairman of the Board -
Jonathan Peacock,
Independent Director -
Christi Shaw,
Independent Director -
Rakesh Sachdev,
Independent Director -
Juan Andres,
Independent Director -
Gregory Summe,
Independent Director -
Michael Severino,
Independent Director -
Jo Natauri,
Director -
Andre Moura,
Director -
Matthew Holt,
Director -
Steven Eck,
Senior Vice President, Chief Accounting Officer -
Mark Murray,
Executive Vice President of the Biomaterials and Advanced Technologies Platform -
Sven Henrichwark,
Executive Vice President of APAC -
Tanya Foxe,
Executive Vice President - Global Operations and Supply Chain -
Christophe Couturier,
Executive Vice President - Services, Strategy and Business Transformation -
James Bramwell,
Executive Vice President - Strategic Partners -
Justin Miller,
Executive Vice President, General Counsel, Secretary -
Michael Wondrasch,
Executive Vice President, Chief Information Officer -
Eric McAllister,
Chief Human Resource Officer, Executive Vice President -
Allison K. Hosak,
Sr. VP of Global Communications & Brand -
Justin M. Miller Esq.,
Exec. VP, Gen. Counsel & Sec. -
Tommy J. Thomas CPA,
VP of Investor Relations -
Steven W. Eck,
Sr. VP, Corp. Controller & Chief Accounting Officer -
Sheri Lewis,
Exec. VP, Global Operations & Supply Chain -
Lan Kang,
Director -
John Carethers,
Director -
Sachs & Co. Llc Stone Bridg...,
-
Sachs & Co. Llc Stone Bridg...,
-
Sheri Lewis,
EVP, Global Ops & Supply Chain -
Mountain Investments Iii, L...,
-
Mala Murthy,
Director -
Brittany Hankamer,
EVP, Chief HR Officer -
Randy Lee Stone,
EVP, Laboratory Solutions -
Corey Walker,
President Laboratory Solutions -
Ashish Kulkarni,
See Remarks -
Sachs & Co. Llcgoldman Sach...,
-
Meghan Henson,
EVP, Chief HR Officer -
Thomas Connolly,
Director -
Joseph R Massaro,
Director -
Kitty Sahin,
EVP, Strategy&Corp Development -
Claudius Sokenu,
EVP, Chief Legal & Compliance -
R. Brent Jones,
EVP, Chief Financial Officer -
Benoit Gourdier,
EVP, Biopharma Production